Squamous cell carcinoma antigen (SCC) in diagnostics and monitoring treatment of patients with cervical cancer
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 7
Abstract
Squamous cell carcinoma antigen (SCC) is the first marker of squamous cell carcinoma and a member of the serin proteinase inhibitor family. Increased concentration of SCC occurs in squamous cancers of the region of the head and neck, oesophagus, larynx, neck of the uterus, and oral cavity. SCC is not a specific marker of squamous cancer. Its increased concentration is noted also in certain cancers and non-cancer diseases. Many scientists have shown the suitability of antigen SCC in assessment of early effects of squamous cancer treatment. In our study we showed the suitability of antigen SCC in diagnostics and monitoring of treatment for patients suffering from cervical squamous cell carcinoma. Together with growth of the degree of clinical advancement, concentration of antigen SCC in the patient’s blood increases. There is a dependency between concentration of antigen SCC before commencement of treatment and further assessment of early and later results of the treatment for patients suffering from cervical squamous cell carcinoma. Concentration of antigen SCC was analysed for 163 patients suffering from cervical squamous cell carcinoma in various degrees of clinical advancement. 118 of them were subject to 5- and 10-year observation after the completed radical treatment. In addition, sensitivity of antigen SCC determinations depending on the degree of clinical advancement was assessed. Results of the analysis indicate a correlation of antigen SCC concentration with the degree of clinical advancement of the disease. Suitability of the marker in monitoring of treatment effects for patients suffering from cervical squamous cell carcinoma was also proved. Thirdly, the dependence of prognosis for patients suffering from cervical squamous cell carcinoma on initial concentration of SCC in the blood before commencement of treatment was shown.
Authors and Affiliations
Marcin Stępień, Jan Kornafel
Keywords
Related Articles
- EP ID EP82409
- DOI -
- Views 75
- Downloads 0
Short interfering RNA in cancer therapy
Despite modern application of surgical treatment as well as radio- and chemotherapy the results of cancer treatment are still disappointing. Genetic engineering brings new hopes and capability of interference in the gen...
Piodermia zgorzelinowa imitująca chorobę Pageta
Przedstawiamy przypadek 72-letniej chorej, u której ze względu na lokalizację owrzodzenia na lewej piersi i początkowo mylnie zinterpretowany obraz histopatologiczny rozpoznano i leczono bezskutecznie przez 9 mies. choro...
Operacje odtwórcze piersi, ocena satysfakcji pacjentek
Wstęp: Rekonstrukcja piersi jest elementem kompleksowego leczenia raka tego narządu. Podstawowym przeciwwskazaniem onkologicznym jest potwierdzone uogólnienie choroby. Natomiast nie ma potrzeby rezygnowania z rekonstruk...
New agents in treatment of metastatic renal cell carcinoma
As renal cell carcinoma appears to be resistant to conventional treatment modalities and results of cytokine-based immunotherapy are far from satisfactory, there is desperate need for new active agents to be discovered....
Ocena skuteczności różnych metod radioterapii przerzutów raka płuca do mózgu
Rak płuca jest najczęściej spotykanym nowotworem złośliwym u mężczyzn – powoduje ok. 1/3 zachorowań i zgonów. Wśród kobiet rak płuca jest drugim co do częstotliwości występowania po raku piersi. Przerzuty do ośrodkowego...